Cargando…

A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience

BACKGROUND: The Bethesda system for reporting thyroid cytopathology (TBSRTC) was introduced to standardize the communication of fine-needle aspiration cytology (FNAC) interpretation between clinicians and pathologists. This study was undertaken to evaluate the diagnostic utility of TBSRTC for report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arul, P., Akshatha, C., Masilamani, Suresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chang Gung University 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138258/ https://www.ncbi.nlm.nih.gov/pubmed/27013451 http://dx.doi.org/10.1016/j.bj.2015.08.001

Ejemplares similares

Histopathological Review of Diagnostic Categories of the Bethesda System for Reporting Thyroid Cytopathology – An Institutional Experience of 5 Years
por: Upadhyaya, Paricha, et al.
Publicado: (2019)

A Different Perspective on Evaluating the Malignancy Rate of the Non-Diagnostic Category of the Bethesda System for Reporting Thyroid Cytopathology: A Single Institute Experience and Review of the Literature
por: Gunes, Pembegul, et al.
Publicado: (2016)

The Diagnostic Performance of Thyroid US in Each Category of the Bethesda System for Reporting Thyroid Cytopathology
por: Park, So Yoon, et al.
Publicado: (2016)

Diagnostic Accuracy of the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC): An Institution Experience
por: Rai, Karima, et al.
Publicado: (2023)

Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology: an institutional perspective
por: Naz, Samreen, et al.
Publicado: (2014)

Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate: An institutional experience
por: Almahari, Sayed Ali, et al.
Publicado: (2019)

Non-invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) Lowers the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology Diagnostic Categories
por: Al-Maghrabi, Hatim, et al.
Publicado: (2022)

Thyroid Nodules Cytopathology Applying the Bethesda System with Histopathological Correlation
por: Zarif, Hawazen A., et al.
Publicado: (2018)

The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study
por: Anand, Bakiarathana, et al.
Publicado: (2020)

Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year tertiary center experience in Thailand
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2018)

Thyroid Cytopathology Reporting by the Bethesda System: A Two-Year Prospective Study in an Academic Institution
por: Mehra, Payal, et al.
Publicado: (2015)

Fine Needle Aspiration of Thyroid Nodules Using the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience in a Rural Setting
por: Guo, Aili, et al.
Publicado: (2017)

Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III
por: Liu, Xiaoli, et al.
Publicado: (2022)

Reproducibility of the Bethesda System for Reporting Thyroid Cytopathology: A Methodological Issue
por: Naderi, Mehdi, et al.
Publicado: (2019)

The Bethesda system for reporting thyroid cytopathology in Colombia: Correlation with histopathological diagnoses in oncology and non-oncology institutions
por: Melo-Uribe, Mario Alexander, et al.
Publicado: (2015)

Fine needle aspiration cytology of atypical (C3) and suspicious (C4) categories in the breast and its histopathologic correlation
por: Arul, P, et al.
Publicado: (2016)

Incidence and Malignancy Rates of Diagnoses in the Bethesda System for Reporting Thyroid Aspiration Cytology: An Institutional Experience
por: Park, Ji Hye, et al.
Publicado: (2014)

Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience
por: Kim, Milim, et al.
Publicado: (2018)

Cytological diagnosis of pediatric thyroid nodule in perspective of the Bethesda System for Reporting Thyroid Cytopathology
por: Pantola, Chayanika, et al.
Publicado: (2016)

Classification of thyroid fine-needle aspiration cytology into Bethesda categories: An institutional experience and review of the literature
por: Alshaikh, Safa, et al.
Publicado: (2018)

Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective
por: Zahid, Adnan, et al.
Publicado: (2021)

FNAC accuracy in diagnosis of thyroid neoplasms considering all diagnostic categories of the Bethesda reporting system: A single-institute experience
por: Hajmanoochehri, Fatemeh, et al.
Publicado: (2015)

The Bethesda System for Reporting Thyroid Cytopathology: Validating at Tribhuvan University Teaching Hospital
por: Acharya, Kunjan, et al.
Publicado: (2021)

Hashimoto’s Thyroiditis Does Not Influence the Malignancy Risk in Nodules of Category III in the Bethesda System
por: Słowińska-Klencka, Dorota, et al.
Publicado: (2022)

Malignancy rate of Bethesda category III thyroid nodules according to ultrasound risk stratification system and cytological subtype
por: Yoo, Won Sang, et al.
Publicado: (2020)

Reproducibility of “The Bethesda System for Reporting Thyroid Cytopathology:” A Retrospective Analysis of 107 Patients
por: Awasthi, Pragati, et al.
Publicado: (2018)

AI diagnosis of Bethesda category IV thyroid nodules
por: Yao, Jincao, et al.
Publicado: (2023)

Malignancy in Thyroid Nodules with Bethesda III Category on Repeat Fine Needle Aspiration Biopsy*
por: Lourdes Ng, Jennifer, et al.
Publicado: (2023)

Correlation between Thyroid Imaging Reporting and Data System and Bethesda System of Reporting of Thyroid Cytopathology of Thyroid Nodule: A Single Center Experience
por: Biswas, Ananya, et al.
Publicado: (2020)

Low reproducibility of equivocal categories of the Bethesda System for Reporting Thyroid Cytology makes the associated risk of malignancy specific to the diagnostic center
por: Słowińska-Klencka, Dorota, et al.
Publicado: (2021)

ODP481 Frequency and outcomes of reporting Bethesda class III thyroid cytopathology- An integrated health network's experience
por: Dantey, Kossivi, et al.
Publicado: (2022)

Evaluation of thyroid nodules classified as Bethesda category III on FNAC
por: Garg, Shiwani, et al.
Publicado: (2017)

Malignancy Rates in Thyroid Nodules Classified as Bethesda Categories III and IV: Retrospective Data from a Tertiary Center
por: Godoi Cavalheiro, Beatriz, et al.
Publicado: (2017)

Multimodality Molecular Imaging (FDG-PET/CT, US Elastography, and DWI-MRI) as Complimentary Adjunct for Enhancing Diagnostic Confidence in Reported Intermediate Risk Category Thyroid Nodules on Bethesda Thyroid Cytopathology Reporting System
por: Basu, Sandip, et al.
Publicado: (2016)

Surgical Outcome and Malignant Risk Factors in Patients With Thyroid Nodule Classified as Bethesda Category III
por: Huang, Jianhao, et al.
Publicado: (2021)

Histopathological Review of Diagnostic Categories of the Milan System for Reporting Salivary Gland Cytopathology – An Institutional Experience of 6 Years
por: Isgor, Irem S., et al.
Publicado: (2021)

The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology
por: Sengul, Ilker, et al.
Publicado: (2023)

Real-world EUROCRINE(®) registry data challenge the reliability of Bethesda cytopathology for thyroid surgery indication
por: Staubitz, Julia I., et al.
Publicado: (2021)

Rates of thyroid malignancy by FNA diagnostic category
por: Williams, Blair A, et al.
Publicado: (2013)

Reproducibility of Cytomorphological Diagnosis and Assessment of Risk of Malignancy of Thyroid Nodules Based on the Bethesda System for Reporting Thyroid Cytopathology: A Tertiary Cancer Center Perspective
por: Panda, Sasmita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_taiucdpf3s3j92inb4jk82v121